FRANK A. KAPRAL, Ph.D.
Staphylococcus aureus strains recovered from patients with toxic shock syndrome were examined for their ability to produce epidermal toxin. Seventy-three percent of 52 strains elaborated the toxin whereas only 18% of 106 control strains did so. There was no significant difference in the hemolysin patterns shown by the two groups of organisms.
Learn more about subscription options.
Register Now for a free account.
KAPRAL FA. Epidermal Toxin Production by Staphylococcus aureus Strains from Patients with Toxic Shock Syndrome. Ann Intern Med. 1982;96:972–974. doi: 10.7326/0003-4819-96-6-972
Download citation file:
Published: Ann Intern Med. 1982;96(6_Part_2):972-974.
Infectious Disease, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only